background respiratory syncyti virus rev major caps sever lower tract disease infant early childhood despite import pathogen license vaccine yet attach glycoprotein g potent import target protect antivirus immune response recombin baculoviru recent emerge new vector since entries immunostimulatori property good biosafeti profil method construct baculovirusbas bacrsvg display value immunogen efficacy entrants immune basic mouse result office provide immune challenge strong serum img mucosa iga induce admit humor specify th well type cell detect lung bacrsvgimmun upon neither lung eosinophilia vaccineinduc weight loss observe subset infect concur data demons administer office induce protect metres promise prophylact vaccine regimen 